Nasdaq Mdna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq mdna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Mdna Today - Breaking & Trending Today

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp

TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a. ....

United States , University Of Pennsylvania , British Columbia , Steven Brem , Christina Cameron , Superkine Immunotherapies , Medicenna Therapeutics Corp , Society For Neuro , Centre For Precision Surgery , Perelman School Of Medicine , Single Administration Of Bizaxofusp , Abramson Cancer Center , Medical Director , Precision Surgery , Perelman School , Survival Outcomes , Recurrent Glioblastoma , Patients Treated , Single Intra Tumoral Administration , Clinical Trials , Localized Infusion , Orphan Drug , Targeted Metalloprotease Activated Superkines , Nasdaq Mdna , Medicenna Therapeutics Corp ,

Medicenna Therapeutics' (MDNA) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Medicenna Therapeutics (NASDAQ:MDNA – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $2.50 price target on the stock. HC Wainwright also issued estimates for Medicenna Therapeutics’ Q2 2024 earnings at ($0.05) EPS, Q3 2024 earnings at […] ....

Renaissance Technologies , Millennium Management , Medicenna Therapeutics Corp , Medicenna Therapeutics Company Profile , Letko Brosseau Associates Inc , Sigma Planning Corp , Worth Venture Partners , Medicenna Therapeutics , Free Report , Get Free Report , Planning Corp , Venture Partners , Therapeutics Corp , Medicenna Therapeutics Daily , Nasdaq Mdna , Reiterated Rating , Hc Wainwright ,

Letko Brosseau & Associates Inc. Grows Stock Holdings in Medicenna Therapeutics Corp. (NASDAQ:MDNA)

Letko Brosseau & Associates Inc. increased its stake in shares of Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating) by 70.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 170,000 shares of the company’s stock after buying an additional 70,000 shares during […] ....

Annandale Capital , Letko Brosseau Associates Inc , Rathbones Group Plc , Sigma Planning Corp , Medicenna Therapeutics Corp , Maven Securities , Securities Exchange Commission , Letko Brosseau , Medicenna Therapeutics , Get Rating , Group Plc , Planning Corp , Empowered Cytokines , Fahar Merchant , Rosemina Merchant , Visit Holdingschannel , Medicenna Therapeutics Daily , Nasdaq Mdna , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Medicenna Therapeutics (NASDAQ:MDNA) Trading Down 1.8%

Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating)’s stock price dropped 1.8% during mid-day trading on Thursday . The stock traded as low as $0.74 and last traded at $0.74. Approximately 70,588 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 100,742 shares. The stock had previously closed at […] ....

Rathbones Group Plc , Annandale Capital , Letko Brosseau Associates Inc , Renaissance Technologies , Medicenna Therapeutics Corp , Millennium Management , Medicenna Therapeutics , Get Rating , Therapeutics Trading Down , Group Plc , Empowered Cytokines , Fahar Merchant , Rosemina Merchant , Medicenna Therapeutics Daily , Nasdaq Mdna ,

Medicenna Therapeutics (NASDAQ:MDNA) Trading Down 1.8%

Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating) was down 1.8% on Thursday . The company traded as low as $0.74 and last traded at $0.74. Approximately 70,588 shares were traded during trading, a decline of 30% from the average daily volume of 100,742 shares. The stock had previously closed at $0.76. Analyst Ratings Changes Separately, […] ....

Medicenna Therapeutics Corp , Millennium Management , Letko Brosseau Associates Inc , Renaissance Technologies , Capital Management , Sigma Planning Corp , Medicenna Therapeutics Company Profile , Medicenna Therapeutics , Get Rating , Therapeutics Stock Down , Planning Corp , Empowered Cytokines , Fahar Merchant , Rosemina Merchant , Medicenna Therapeutics Daily , Nasdaq Mdna ,